Funder: Novo Nordisk Foundation
Due Dates (Anticipated): August 2027 (Call closes)
Funding Amounts: DKK 6–22 million per grant over 3–5 years; total budget up to DKK 89 million
Summary: Supports larger, noncommercial clinical trials in Denmark that improve patient treatment through medicines, technology, and better treatment routines.
Key Information: Main applicants must be specialist physicians with an MD, employed at the Danish hospital anchoring the project.
Description
The Novo Nordisk Foundation supports investigator-initiated clinical trials involving patients and aiming to improve existing treatment routines. The programme funds single-centre and multicentre national trials, as well as international collaborations with clinical trial work in Denmark. Randomized controlled trials are preferred, but nonrandomized trials are accepted. Supported work includes medicines and repositioning, medical devices, surgery, radiotherapy, advanced genetic and cell therapies, physiotherapy, and rehabilitation interventions.
The goal is to improve patient treatment and quality of care through new medicines and technology. Clinical relevance, scientific quality, and good clinical practice are central requirements. Trials with an industrial or commercial purpose, and projects solely concerning discovery, product development, or implementation, are not supported.
